Algocell

Company Overview

Snapshot

Founded in March 2023 by David Almagor, Omri Schanin, and Eyal Betzalel, Algocell operates with 1–10 employees. The company has raised $2.8 million across three funding rounds from three investors. In July 2025, Algocell secured Pre-Seed funding from Good Company VC.

Business overview

Algocell is a Health Tech & Life Sciences company focused on optimizing bioprocessing for cell-based product companies. The company leverages digital twin technology to enable data-driven decisions, aiming to balance cost, production volume, and product quality while minimizing resource consumption and trial-and-error processes. Algocell operates within the Pharma & Medical Biotechnology sector, utilizing Simulation & Imaging technologies.

Company Intelligence Q&A

When was Algocell founded and by whom?

Algocell was founded in March 2023 by co-founders David Almagor, Omri Schanin, and Eyal Betzalel.

What type of funding did Algocell receive in February 2024?

In February 2024, Algocell received Pre-Seed funding from angel investors David Almagor.

Has Algocell received any grants?

In June 2025, Algocell received a grant from the Israel Innovation Authority.

What is Algocell's primary business model?

Algocell primarily operates with a B2B (business-to-business) model, serving other companies in the cell-based industry.